Skipping toward Personalized Molecular Medicine
- 27 December 2007
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (26) , 2719-2722
- https://doi.org/10.1056/nejme0707795
Abstract
“Personalized molecular medicine.” As with other catchy terms for big ideas, such as “reversing global warming” and “renewable energy,” the concept of personalized molecular medicine is certainly important, but the path to achieving it is far from clear. When such phrases are considered, definitions are important. Does personalized molecular medicine mean the tailoring of drugs for the individual patient, an approach that evokes images of Bones on Star Trek making instantaneous diagnoses with his Tricorder followed by loud pneumatic injections of customized drugs? Such a concept would place the realization of this technology in the same time frame as the . . .Keywords
This publication has 8 references indexed in Scilit:
- Local Dystrophin Restoration with Antisense Oligonucleotide PRO051New England Journal of Medicine, 2007
- Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophyExpert Opinion on Biological Therapy, 2007
- Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophyHuman Mutation, 2006
- Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathologyNature Medicine, 2006
- 128th ENMC International Workshop on ‘Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy’ 22–24 October 2004, Naarden, The NetherlandsNeuromuscular Disorders, 2005
- Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal musclesProceedings of the National Academy of Sciences, 2004
- Very mild muscular dystrophy associated with the deletion of 46% of dystrophinNature, 1990
- Dystrophin: The protein product of the duchenne muscular dystrophy locusCell, 1987